Epstein-Barr Virus Antibodies in Whole Blood Spots: A Minimally Invasive Method for Assessing an Aspect of Cell-Mediated Immunity
Thomas W. McDade, PhD,
Joy F. Stallings, PhD, MPH,
Adrian Angold, MRCPsych,
E. Jane Costello, PhD,
Mary Burleson, PhD,
John T. Cacioppo, PhD,
Ronald Glaser, PhD and
Carol M. Worthman, PhD
From the Department of Anthropology (T.W.McD.), Northwestern University, Evanston, IL; Department of Anthropology (J.F.S., C.M.W.), Emory University, Atlanta, GA; Center for Developmental Epidemiology (A.A., E.J.C.), Duke University Medical Center, Durham, NC; Department of Social and Behavioral Sciences (M.B.), Arizona State University West, Phoenix, AZ; Department of Psychology (J.T.C.), University of Chicago, Chicago, IL; and Department of Molecular Virology, Immunology and Medical Genetics (R.G.), Ohio State University Medical Center, Columbus, OH.

View larger version (22K):
[in a new window]
|
Fig. 1. Correlation between plasma and blood spot EBV p18-VCA antibody titer.
|
|

View larger version (23K):
[in a new window]
|
Fig. 2. Correlation between blood spot ELISA method and plasma IF.
|
|

View larger version (22K):
[in a new window]
|
Fig. 3. Stability of EBV p18-VCA antibodies in whole blood spots over 8 weeks at 37°C, room temperature, and 4°C.
|
|

View larger version (15K):
[in a new window]
|
Fig. 4. Relationship between traumatic life events and EBV p18-VCA antibody titer under conditions of low and high life strain. Pearson R indicates the strength of the relationship between number of life events and log p18-VCA antibody titer, controlling for age.
|
|
Copyright © 2000 by the American Psychosomatic Society